The Kyowa Kirin Group is a Japanese pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world. Its flagship business Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease,
Below is the contact information for Dubai office Kyowa Kirin Pharma FZ-LLC Office 106, Building 49, Dubai Healthcare City, Dubai, United Arab Emirates. PO Box 62468 T: +971 4 581 3700 ©2020 Kyowa Kirin International plc.
News releases issued by Kyowa Kirin are intended to inform stakeholders of information related to the company's business in a fair manner. Though it may include information concerning pharmaceutical products (including products under development) , it is not for the purpose of promoting, advertising ...
Grünenthal buys into Kyowa Kirin's mature medicines portfoli... German pharma Grünenthal has started the process of taking ownership of 13 ageing medicines developed by Japan's Kyowa Kirin, which are currently sold by affiliate companies across Europe.< ...
Kyowa Kirin expects the solar plant to be up and running by March 2023, allowing it to offset around 1,029 tonnes of carbon dioxide (CO2) per year. This is the first time for Kyowa Kirin to use the onsite PPA model, in which the installation of solar power generation equipment is...
Kyowa Kirin has been selling Poteligeo in Japan since 2012, and the company says its approval in the US is a key milestone on the path to becoming a global specialty pharmaceutical company. Three years ago itjoined forceswith Bristol-Myers Squib b to test it alongside BMS’ PD-1 inhibitor...
「オーディエンスの興味」はasahikasei-pharma.co.jpへの訪問者がどのサイトに関心をもって閲覧しているのかを明らかにします。 上位のカテゴリー 表示できるデータはありません 表示できるデータはありません もっと深くオーディエンスを理解する必要がありますか?
Kyowa Kirin Pharmaceutical Development Limited Kyowa Kirin Ireland Limited Kyowa Kirin Pharma s.r.o Kyowa Kirin Pharma FZ-LLC Kyowa Kirin GmbH Kyowa Kirin AB Kyowa Kirin Pharma B.V. Kyowa Kirin S.r.l. Kyowa Kirin Holdings B.V., French PE Kyowa Kirin Phar...
The Kyowa Kirin Group is a Japanese pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world. Its flagship business Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease,